Circadian- and Sex-Dependent Increases in Intravenous Cocaine Self-Administration in Npas2 Mutant Mice
Total Page:16
File Type:pdf, Size:1020Kb
Research Articles: Behavioral/Cognitive Circadian- and sex-dependent increases in intravenous cocaine self-administration in Npas2 mutant mice https://doi.org/10.1523/JNEUROSCI.1830-20.2020 Cite as: J. Neurosci 2020; 10.1523/JNEUROSCI.1830-20.2020 Received: 15 July 2020 Revised: 13 November 2020 Accepted: 18 November 2020 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.jneurosci.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2020 the authors 1 Circadian- and sex-dependent increases in intravenous cocaine self-administration in Npas2 mutant mice 2 3 Abbreviated title: Increased cocaine intake in female Npas2 mutants 4 5 Lauren M. DePoy1,2, Darius D. Becker-Krail1,2, Wei Zong3, Kaitlyn Petersen1,2, Neha M. Shah1, Jessica H. 6 Brandon1, Alyssa M. Miguelino1, George C. Tseng3, Ryan W. Logan1,2,4, *Colleen A. McClung1,2,4 7 8 1Department of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine, 9 15219 10 2Center for Neuroscience, University of Pittsburgh, 15261 11 3Department of Biostatistics, University of Pittsburgh, 15261 12 4Center for Systems Neurogenetics of Addiction, The Jackson Laboratory, 04609 13 14 15 *Corresponding Author: 16 Colleen A. McClung, PhD 17 450 Technology Dr. Ste 223 18 Pittsburgh, PA 15219 19 412-624-5547 20 [email protected] 21 22 Key words: circadian, sex-differences, cocaine, self-administration, substance use, Npas2 23 24 Pages: 37 25 Figures: 9 26 Extended data tables: 3 27 Abstract: 250 28 Introduction: 552 29 Discussion: 1490 30 31 Disclosures: 32 All authors have no financial disclosures or conflicts of interest to report. 33 34 Acknowledgements: 35 We would like to thank Mariah Hildebrand and Laura Holesh for animal care and genotyping. We thank Drs. 36 Steven McKnight and David Weaver for providing the Npas2 mutant mice. This project used the University of 37 Pittsburgh Health Sciences Sequencing Core at UPMC Children’s Hospital of Pittsburgh, (RNA sequencing). 38 Cocaine was provided by NIDA via the NIH drug distribution center. This work was funded by the National 39 Institutes of Health: DA039865, DA041872, DA039841, DA042886 (PI: Colleen McClung, PhD) and DA046117 40 (PI: Lauren DePoy). 41 42 Author contributions: 1 43 LMD, RWL and CAM participated in research design; LMD, DBK, WZ, GCT, RWL, and CAM contributed to the 44 writing and editing of the manuscript; LMD conducted experiments with the assistance of DBK, KP, NMS, JHB 45 and AMM; LMD, DBK and WZ performed data analysis. 2 46 Abstract 47 48 Substance use disorder is associated with disruptions in circadian rhythms. The circadian transcription 49 factor neuronal PAS domain protein 2 (NPAS2) is enriched in reward-related brain regions and regulates 50 reward, but its role in substance use is unclear. To examine the role of NPAS2 in drug taking, we measured 51 intravenous cocaine self-administration (acquisition, dose-response, progressive ratio, extinction, cue-induced 52 reinstatement) in wild-type (WT) and Npas2 mutant mice at different times of day. In the light (inactive) phase, 53 cocaine reinforcement was increased in all Npas2 mutants, while self-administration and motivation were 54 affected sex-dependently. These sex differences were amplified during the dark (active) phase with Npas2 55 mutation increasing self-administration, reinforcement, motivation, extinction responding and reinstatement in 56 females, but only reinforcement in males. To determine whether circulating hormones are driving these sex 57 differences, we ovariectomized WT and Npas2 mutant females and confirmed that unlike sham controls, 58 ovariectomized mutant mice showed no increase in self-administration. To identify whether striatal brain 59 regions are activated in Npas2 mutant females, we measured cocaine-induced 'FosB expression. Relative to 60 WT, 'FosB expression was increased in D1+ neurons in the nucleus accumbens core and dorsolateral 61 striatum in Npas2 mutant females after dark phase self-administration. We also identified potential target 62 genes that may underlie the behavioral responses to cocaine in Npas2 mutant females. These results suggest 63 NPAS2 regulates reward and activity in specific striatal regions in a sex and time of day specific manner. 64 Striatal activation could be augmented by circulating sex hormones, leading to an increased effect of Npas2 65 mutation in females. 66 3 67 Significance Statement 68 69 Circadian disruptions are a common symptom of substance use disorders and chronic exposure to 70 drugs of abuse alters circadian rhythms, which may contribute to subsequent substance use. Diurnal rhythms 71 are commonly found in behavioral responses to drugs of abuse with drug sensitivity and motivation peaking 72 during the dark (active) phase in nocturnal rodents. Emerging evidence links disrupted circadian genes to 73 substance use vulnerability and drug-induced alterations to these genes may augment drug-seeking. The 74 circadian transcription factor NPAS2 is enriched in reward-related brain regions and regulates reward, but its 75 role in substance use is unclear. To examine the role of NPAS2 in drug taking, we measured intravenous 76 cocaine self-administration in wild-type and Npas2 mutant mice at different times of day. 77 4 78 Introduction 79 Circadian disruptions are a common symptom of many psychiatric disorders (Kowatch et al., 1992; 80 Morgan & Malison, 2007; Matuskey et al., 2011), including substance use disorder (SUD)(Spanagel et al., 81 2005; McClung, 2007; Logan et al., 2014; Lauren M DePoy et al., 2017). Diurnal rhythms in the behavioral 82 responses to drugs of abuse are common with drug sensitivity and drug use peaking during the active 83 compared to inactive phase, or dark and light respectively in nocturnal rodents (Baird & Gauvin, 2000; Abarca 84 et al., 2002; Roberts et al., 2002; Sleipness et al., 2005). Chronic exposure to drugs of abuse alters circadian 85 rhythms, which may contribute to subsequent substance use (SU)(Roberts et al., 2002; Logan et al., 2014; 86 Lauren M DePoy et al., 2017). Emerging evidence from rodents and humans links disrupted circadian genes to 87 SU vulnerability (Dong et al., 2011; Forbes et al., 2012; Ozburn et al., 2012, 2013; Blomeyer et al., 2013; 88 Gamsby et al., 2013; Bi et al., 2014; Baranger et al., 2016) and drug-induced alterations to these genes may 89 augment drug-seeking. 90 Almost every cell in the brain and body expresses a molecular clock, comprised of several interlocking 91 transcriptional-translational feedback loops (Reppert & Weaver, 2002; Ko & Takahashi, 2006; Takahashi, 92 2016). The molecular clock is regulated by Circadian Locomotor Output Cycles Kaput (CLOCK) or its 93 homologue, neuronal PAS domain protein 2 (NPAS2), which dimerize with Brain and Muscle ARNT-like 1 94 (BMAL1) to control transcription of many genes. After translation, these proteins enter the nucleus and inhibit 95 the transcriptional activity of (CLOCK/NPAS2)/BMAL1, closing the negative feedback loop (Ko & Takahashi, 96 2006). Our laboratory has previously demonstrated that mutations in Clock lead to increased cocaine and 97 alcohol intake in mice (McClung et al., 2005; Ozburn et al., 2012, 2013) and a loss of diurnal rhythmicity in 98 cocaine self-administration (Roberts et al., 2002). We have also shown that while Clock mutation increases 99 cocaine preference, Npas2 mutation attenuates preference (Ozburn et al., 2015a). NPAS2 is similar to CLOCK 100 in structure and function, yet relative to CLOCK, NPAS2 expression and promotor binding is highly rhythmic in 101 the striatum (Garcia et al., 2000a; Ozburn et al., 2015a), including the nucleus accumbens (NAc), a major 102 neural substrate of reward (Wise & Rompre, 1989). In fact, in the NAc rhythms in Npas2 are more highly 103 affected by cocaine than Clock (Falcon et al., 2013) and Npas2 knockdown increases glutamatergic 104 transmission onto dopamine Drd1-expressing neurons (Parekh et al., 2019). Together, these findings suggest 5 105 NPAS2 might play uniquely important role in the regulation of reward within the striatum. 106 This study aimed to determine whether NPAS2 regulates intravenous cocaine self-administration, a 107 translational model of drug taking, the reinforcing and motivational properties of drugs and relapse-like 108 behavior. We investigated whether Npas2 mutation modulates the diurnal rhythm in drug taking by measuring 109 self-administration during both the light and dark phase. We also examined whether Npas2 mutation 110 differentially impacts male and female mice since sex differences are prominent in circadian rhythms (Hatcher 111 et al., 2018) and SUD (Becker & Hu, 2008). We find that NPAS2 regulates cocaine self-administration 112 differentially across sex and time of day (TOD). Ovarian hormones and cocaine-induced expression of striatal 113 'FosB are associated with increased self-administration in Npas2 mutant females during the dark phase. 114 Furthermore, we identify potential target genes that might underlie the behavioral responses to cocaine in 115 Npas2 mutant females. 116 6 117 Methods and Materials 118 Subjects. Male and female Npas2 mutant mice or wild-type (WT) littermates, maintained on a C57BL/6J 119 background, were used. These mice were originally described by Garcia et al., 2000. This mutation removes 120 the bHLH domain of NPAS2, leaving the majority of the protein intact, but incapable of binding to BMAL1 121 (Garcia et al., 2000b). Adult mice were maintained on a 12:12 light-dark cycle with lights on (Zeitgeber Time 122 (ZT0)) at 0700 or 1900. Behavioral testing occurred during the light phase from ZT2-7, unless specifically 123 indicated as a dark phase experiment (ZT14-19). Food and water were provided ad libitum unless otherwise 124 indicated. Procedures were approved by the University of Pittsburgh IACUC. 125 126 Drug.